Chemical Accidents at Two Andhra Pradesh Pharma Plants Raise Safety Concerns
Veröffentlicht: 13.07.2026 um 20:21 Uhr, Redaktion boerse-global.de
Three workers were seriously injured in two separate chemical accidents at pharmaceutical manufacturing facilities in Andhra Pradesh, India, on July 13, 2026, prompting calls for urgent investigations into workplace safety standards at the region's industrial hubs.
Sulphuric Acid Leak at Visakhapatnam Pharma City
Two employees were injured when a drum containing sulphuric acid burst at a pharmaceutical unit inside the Jawaharlal Nehru Pharma City (JNPC) in Visakhapatnam. The accident happened on Monday when a chain-pulley system snapped, causing a heavy drum to fall and rupture on impact.
These accidents are a stark reminder of what can go wrong when hazardous substances are not properly managed. In the UK, the Control of Substances Hazardous to Health (COSHH) regulations require employers to assess and control risks from dangerous chemicals. A free toolkit provides 43 ready-to-use templates and checklists to help you document your assessments and implement controls. Download the free COSHH Risk Assessment Toolkit
The chemist involved suffered chemical burns to his face and right shoulder. Preliminary reports point to mechanical failure in the facility's logistics equipment as the cause.
Ganisetty Satyanarayana, representing the Pharma City staff and workers union, has demanded a formal inquiry into safety protocols at the site. The union flagged the hoisting equipment failure as a critical area for investigation, questioning whether maintenance schedules were being properly followed.
Severe Injuries at Torrent Pharma
On the same day, a worker named Nagaraju was severely injured in a chemical spill at a Torrent Pharma facility in the Parawada Industrial Area of the Anakapalli district.
Colleagues provided immediate first aid before the victim was rushed to a local hospital for emergency treatment. The specific chemical involved has not been fully disclosed, but the severity of the injuries required specialist medical care.
Regulatory Pressure Mounts on Indian Pharma Sector
The accidents come amid heightened regulatory activity across India's pharmaceutical industry. Earlier this month, the Maharashtra Food and Drug Administration (FDA) ordered Cadila Pharmaceuticals to recall its Aciloc 150 Plus and Aciloc 300 Plus medications. The recall, covering stock worth approximately ?2.45 crore, was issued over branding concerns that could lead to dangerous drug mix-ups. Authorities conducted raids across Pune, Nagpur, and Bhiwandi to halt distribution of the affected products under the Drugs and Cosmetics Act of 1940.
The region has seen a string of safety-related incidents in recent days. On July 11, a crude oil tanker exploded in the Khargone district during a welding operation, killing one person and injuring two others. Firefighters in nearby Vijayawada were deployed on July 12 to tackle blazes at an ice cream manufacturing unit and a transport mechanic shed where seven buses were destroyed.
As the article shows, even routine equipment failures can lead to serious injuries. Having a thorough risk assessment process is the first line of defence. The free Risk Assessment Toolkit includes 41 templates covering fire safety, manual handling, lone working and more — everything you need to keep your safety documentation complete and compliant. Download the free Risk Assessment Toolkit
The back-to-back chemical injuries at JNPC and Torrent Pharma have intensified scrutiny of labour safety in Andhra Pradesh's pharmaceutical manufacturing hubs, with labour representatives urging stricter enforcement of industrial handling procedures to prevent further casualties.
Disclaimer zu unseren Artikeln: Keine Anlageberatung, keine Kauf oder Verkaufsempfehlung. Angaben zu Kursen, Unternehmen und Märkten ohne Gewähr; Änderungen jederzeit möglich. Börsengeschäfte können zu hohen Verlusten führen. Unsere Beiträge werden ganz oder teilweise automatisiert mit Unterstützung von AI erstellt und geprüft.
